Jenny Sundqvist, CEO, InDex Pharmaceuticals Holding 00:00:00
Jenny Sundqvist has extensive experience of research organizations and marketing of approved medicines. She has previously, among other things, been Chief Commercial Officer at Isofol Medical, Head of Portfolio Management for AstraZeneca’s global oncology portfolio and Global Brand Manager for AstraZeneca’s asthma product Symbicort. She has a BSc in International Trade & Finance from Louisiana State University and an MBA from McCombs School of Business.